Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy

OBJECTIVE: To investigate the longitudinal pharmacokinetics, safety and efficacy of lopinavir/ritonavir (LPV/r) in HIV-infected infants initiating combination antiretroviral therapy (cART) between 2 weeks and 6 months of age. METHOD: A prospective, open-label, multicenter Phase I/II study of LPV/r-b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chadwick, Ellen G., Yogev, Ram, Alvero, Carmelita G., Hughes, Michael D., Hazra, Rohan, Pinto, Jorge A., Robbins, Brian L., Heckman, Barbara E., Palumbo, Paul E., Capparelli, Edmund V.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068474/
https://ncbi.nlm.nih.gov/pubmed/21297419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e32834403f6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge